News
5h
The Brighterside of News on MSNLifesaving new vaccine protects against multiple types of cancerWhen your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...
4d
News Medical on MSNNK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trialA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results